Infusion and persistent care administration firm Uptiv Well being introduced a partnership with the automation platform Lamar Well being to implement AI-powered automation for referral consumption and prior authorization processes.
Uptiv presents infusion remedy for sufferers with persistent circumstances through a hybrid mannequin that merges personalized in-clinic care with a digital platform.
Along with conventional infusion companies, Uptiv gives care coordination, psychological well being teaching and different whole-person care companies.
Lamar Well being gives an AI-powered automation platform aimed particularly at specialty treatment workflows.
The corporate was based by Stanford Medication, McKesson and CoverMyMeds, and it’s backed by Y Combinator and PennyJar Capital, Wholesome VC, Flex Capital, Dnipro VC and Shah Capital.
Lamar’s platform connects to main EHR programs and learns to enhance authorization processes.
The partnership goals to combine Lamar Well being’s specialty medication-focused AI platform into Uptiv Well being’s operations to streamline administrative workflows and scale back the time to remedy for sufferers with persistent circumstances.
Lamar Well being’s AI platform automates complicated administrative duties within the prior authorization course of, which the corporate says has usually been laborious and topic to delays.
The purpose is to minimize the authorization timeline and permit sufferers to begin remedy sooner, lower labor prices linked to consumption and prior authorization processes, redistribute employees time from paperwork to affected person interactions, improve the time from referral to remedy, and facilitate connecting with EHRs to take away pointless information entry and documentation.
“Our partnership with Lamar Well being permits us to allocate assets away from administrative burdens and towards creating distinctive affected person experiences that set us aside within the market,” Torben Nielsen, CEO of Uptiv Well being, mentioned in a press release.
THE LARGER TREND
In 2024, Uptiv Well being partnered with Lyn Well being to merge infusion remedy with persistent care administration by way of an providing dubbed Uptiv360. By the partnership, sufferers bear an onboarding course of through an app, adopted by an analysis by a nurse practitioner throughout an infusion go to.
Inside 48 hours, sufferers are linked with a Lyn Well being care group to entry digital persistent care administration care, together with behavioral well being companies.
Additionally final 12 months, Uptiv Well being opened an infusion middle in Troy, Michigan.
The middle collaborates with referring physicians, hospital programs and payers to offer seamless and accessible look after infusion sufferers with persistent circumstances, together with a number of sclerosis, Crohn’s illness, colitis, rheumatoid arthritis, lupus, extreme bronchial asthma and allergy symptoms.
Uptiv launched in 2023 with $7.5 million in seed funding, alongside the opening of its flagship infusion middle in Westland, Michigan.
Discussion about this post